Demographic Factors, Attitudes, and Pre-Existing Conditions Impacting COVID-19 Vaccine Hesitancy
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
We aimed to understand factors that distinguish vaccine hesitancy from early uptake or refusal to inform public health strategies for the next emergent infectious disease pandemic and clinician-patient communication around vaccine decision-making. The study included 10,176 participants of the Colorado Center for Personalized Medicine biobank who completed a survey in Summer 2021 which included information on COVID-19 vaccine hesitancy, attitudes, and uptake. Survey data were linked to electronic health records prior to the COVID-19 pandemic to catalogue pre-existing health conditions. Early COVID-19 vaccine uptake was high (N=9,873, 96.1%), consistent with high health literacy in this population. While many demographic factors, vaccine considerations, and pre-existing conditions distinguished early uptake from hesitancy or refusal ( P <0.05), only two characteristics distinguished the hesitant from the refusal group. Hesitant individuals were more likely than refusers to report good (31.9% versus 25.8%) or fair or poor (16.4% versus 13.4%) health. Also, they were less likely to report trust in scientists as a key factor impacting their decision to receive the COVID-19 vaccine (15.9% versus 25.8%). These findings highlight the urgent need for more tailored public health strategies to reach the distinct group of individuals who remain open to vaccination. Healthcare professionals may be especially well-positioned to address these concerns in clinical conversations by connecting individual health status and pre-existing conditions to the benefits of vaccination.
Clinical Trials Registry
N/A
Highlights
-
Many factors distinguish uptake of COVID-19 vaccines from hesitancy or refusal.
-
Poorer health and trust in science differentiated hesitancy from refusal.
-
These results may guide early vaccine uptake and readiness for future pandemics.